International Clinical Trial: A Single-Arm, Open-Label, Single-Center Study Evaluating the Efficacy and Safety of Low-Dose Radiotherapy Combined with Pemetplimab and Standard Therapy in Patients with Advanced Pancreatic Cancer

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118369) titled 'A Single-Arm, Open-Label, Single-Center Study Evaluating the Efficacy and Safety of Low-Dose Radiotherapy Combined with Pemetplimab and Standard Therapy in Patients with Advanced Pancreatic Cancer' on Feb. 4.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Zhejiang Provincial People's Hospital

Condition: Pancreatic cancer

Recruitment Status: Recruiting

Phase: 0

Date of First Enrollment: 2025-12-15

Target Sample Size: Therapy group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=180866

Disclaimer: Curated by HT Syndicat...